Clinical trials
Phase 1/2 Immunologic Deficiency Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 3 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Beijing 302 Hospital | 1 |
| Children's Hospital of Philadelphia | 1 |
| Columbia University | 1 |
| Jasper Therapeutics, Inc. | 1 |
| Lisa Satter | 1 |
| St. Jude Children's Research Hospital | 1 |
| Sumitomo Pharma Switzerland GmbH | 1 |
| University of Aarhus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunologic Deficiency Syndromes | 13 |
| Leukemia | 3 |
| Agammaglobulinemia | 2 |
| Hemoglobinopathies | 2 |
| Warts | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Anemia | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Bone Marrow Failure Disorders | 1 |
| Congenital Bone Marrow Failure Syndromes | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.